Company Overview

Founded: 2018

Headquarters: Knoxville, Tennessee

Market Cap: $1.8M (as of Q4 2024)

Share Price: $0.05

Regulatory Status: Operating ketamine clinics under existing medical regulations

Company Link

Revitalist Lifestyle and Wellness Ltd.

Core Development Programs

Primary Research Focus

• Main Compounds: Ketamine therapy
• Target Conditions: Depression, PTSD, Chronic Pain, Anxiety
• Development Stage: Active clinical operations
• Expected Milestones: Clinic network expansion

Clinical Pipeline

• Lead Program Status: Operating ketamine clinics
• Secondary Programs: Mental health services
• Trial Locations: Multiple US locations
• Number of Patients: Thousands treated annually

Technology Platform

Drug Development Approach

• Synthesis Method: N/A (clinical service provider)
• Delivery System: In-clinic therapeutic protocols
• Patent Status: Proprietary treatment protocols
• Unique Technology: Integrated wellness approach

Research Infrastructure

• Lab Facilities: Clinical treatment centers
• Research Partnerships: Healthcare providers
• Equipment/Technology: Modern clinical equipment
• Data Management: Patient tracking system

Financial Position

Current Finances

• Cash Position: $500K
• Burn Rate: $200K monthly
• Revenue: $5M annually (2024)
• Debt: $3M in various obligations

Funding History

• Recent Raises: $2M private placement (2023)
• Major Investors: Private investors
• Grant Funding: Limited
• Expected Runway: Through Q2 2025

Management Team

Key Leadership

• CEO Background: Kathryn Walker – Founder and CEO, experienced healthcare professional
• Scientific Team: Medical directors at each location
• Advisory Board: Mental health professionals
• Board of Directors: Healthcare and business experts

Market Strategy

Commercial Approach

• Target Market Size: $8B mental health treatment market
• Pricing Strategy: Premium service model
• Distribution Plans: Regional clinic expansion
• Partnership Strategy: Healthcare provider networks

Competitive Position

• Main Competitors: Field Trip Health, Numinus Wellness
• Key Advantages: Established clinical protocols
• Market Share: Growing presence in southeastern US
• Barriers to Entry: Clinical expertise, regulatory compliance

Risk Assessment

Development Risks

• Clinical Trial Risks: Treatment outcome consistency
• Regulatory Hurdles: State-by-state regulations
• Technical Risks: Operational scaling
• Timeline Risks: Expansion pace

Market Risks

• Competition: Increasing clinic operators
• Funding Risks: Capital needs for expansion
• Regulatory Changes: Healthcare regulation evolution
• Patent Protection: Treatment protocol IP

Investment Metrics

Key Performance Indicators

• Cash per Share: $0.01
• Institutional Ownership: 5%
• Insider Ownership: 30%
• Short Interest: 0.2%

Analyst Coverage

• Number of Analysts: 0
• Price Targets: N/A
• Consensus Rating: N/A
• Recent Changes: No current coverage

Development Timeline

Near-Term Catalysts

• Next 6 Months: Additional clinic openings
• 12-Month Outlook: Revenue growth targets
• Long-term Goals: National clinic presence

Regulatory Pathway

• FDA Status: Operating under existing medical regulations
• Other Jurisdictions: US state-by-state compliance
• Expected Approvals: Following state frameworks

Standard Disclaimer

This analysis is provided for informational purposes only and does not constitute investment advice. The psychedelic medicine sector involves significant risks including, but not limited to, clinical trial failures, regulatory challenges, market volatility, and potential loss of investment. Companies in this sector are often in early development stages with no approved products or revenue. The regulatory landscape for psychedelic medicines is evolving and uncertain. Past performance does not guarantee future results. Investors should conduct their own due diligence and consult with financial and legal advisors before making any investment decisions. Market conditions and company circumstances can change rapidly. All information presented is subject to update and revision. Author(s) may have positions in securities mentioned.

Learn More About Psychedelic Medicine Investments

For a comprehensive overview of the psychedelic medicine investment landscape, including market analysis, regulatory environment, and investment strategies, read our in-depth guide: The Psychedelic Renaissance: A New Frontier in Mental Health Treatment and Investment Opportunities